Treatment of Diffuse Large B Cell Lymphoma
NCT01949818
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Large B Cell Lymphoma
Interventions
DRUG:
Yangzhengxiaoji capsule combined with CHOP regimen
DRUG:
CHOP regimen
Sponsor
Mingzhi Zhang